Involvement of non-coding RNAs in chemo- and radioresistance of colorectal cancer

Risultato della ricerca: Chapter

21 Citazioni (Scopus)

Abstract

Despite recent progress in understanding the cancer signaling pathways and in developing new therapeutic strategies, however, the resistance of colorectal cancer (CRC) cells to chemo- and radiotherapy represents the main hurdle to the successful treatment, leading to tumor recurrence and, consequently, a poor prognosis. Therefore, overcoming drug and radiation resistance, enhancing drug and radiation sensitivity of CRC cells, and improving the effi cacy of chemo- and radiotherapy have an important signifi cance in the treatment of CRC. The identifi cation of new molecular biomarkers which can predict therapy response and prognosis is one of the most signifi cant aims in pharmacogenomics and cancer research. Recent studies showed that non-coding RNAs (ncRNAs), such as microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), may play important roles in the regulation of chemo- and radioresistance of CRC, by controlling several signaling pathways, including cell cycle, proliferation, apoptosis and DNA damage repair. Recent data have demonstrated that selective modulation of the ncRNA activity can improve the response to chemo- and radiotherapy, providing an innovative anti- tumor approach based on a ncRNA-related gene therapy. Therefore, ncRNAs could not only be useful as predictive and prognostic biomarkers but also serve as targets for the development of novel therapeutic strategies to overcome drug and radiation resistance in CRC. In this chapter, we discuss the involvement of ncRNAs in chemo- and radiotherapy resistance of CRC, highlighting the impact of these molecules in prediction of the treatment response and modifi cation of the therapy, and describing possible intracellular pathways involved in these processes.
Lingua originaleEnglish
Titolo della pubblicazione ospiteAdvances in Experimental Medicine and Biology - Non-coding RNAs in Colorectal Cancer
Pagine207-228
Numero di pagine22
Stato di pubblicazionePublished - 2016

Fingerprint

Untranslated RNA
Chemotherapy
Radiotherapy
Colorectal Neoplasms
Biomarkers
Radiation
Cations
Tumors
Cells
Drug Therapy
Long Noncoding RNA
Pharmaceutical Preparations
Gene therapy
Drug Resistance
Therapeutics
MicroRNAs
Neoplasms
Repair
Modulation
Apoptosis

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)

Cita questo

Fanale, D., Castiglia, M., Russo, A., & Bazan, V. (2016). Involvement of non-coding RNAs in chemo- and radioresistance of colorectal cancer. In Advances in Experimental Medicine and Biology - Non-coding RNAs in Colorectal Cancer (pagg. 207-228)

Involvement of non-coding RNAs in chemo- and radioresistance of colorectal cancer. / Fanale, Daniele; Castiglia, Marta; Russo, Antonio; Bazan, Viviana.

Advances in Experimental Medicine and Biology - Non-coding RNAs in Colorectal Cancer. 2016. pag. 207-228.

Risultato della ricerca: Chapter

Fanale, D, Castiglia, M, Russo, A & Bazan, V 2016, Involvement of non-coding RNAs in chemo- and radioresistance of colorectal cancer. in Advances in Experimental Medicine and Biology - Non-coding RNAs in Colorectal Cancer. pagg. 207-228.
Fanale D, Castiglia M, Russo A, Bazan V. Involvement of non-coding RNAs in chemo- and radioresistance of colorectal cancer. In Advances in Experimental Medicine and Biology - Non-coding RNAs in Colorectal Cancer. 2016. pag. 207-228
Fanale, Daniele ; Castiglia, Marta ; Russo, Antonio ; Bazan, Viviana. / Involvement of non-coding RNAs in chemo- and radioresistance of colorectal cancer. Advances in Experimental Medicine and Biology - Non-coding RNAs in Colorectal Cancer. 2016. pagg. 207-228
@inbook{055c7e19677e4ba9b33e1ceabc6d33ae,
title = "Involvement of non-coding RNAs in chemo- and radioresistance of colorectal cancer",
abstract = "Despite recent progress in understanding the cancer signaling pathways and in developing new therapeutic strategies, however, the resistance of colorectal cancer (CRC) cells to chemo- and radiotherapy represents the main hurdle to the successful treatment, leading to tumor recurrence and, consequently, a poor prognosis. Therefore, overcoming drug and radiation resistance, enhancing drug and radiation sensitivity of CRC cells, and improving the effi cacy of chemo- and radiotherapy have an important signifi cance in the treatment of CRC. The identifi cation of new molecular biomarkers which can predict therapy response and prognosis is one of the most signifi cant aims in pharmacogenomics and cancer research. Recent studies showed that non-coding RNAs (ncRNAs), such as microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), may play important roles in the regulation of chemo- and radioresistance of CRC, by controlling several signaling pathways, including cell cycle, proliferation, apoptosis and DNA damage repair. Recent data have demonstrated that selective modulation of the ncRNA activity can improve the response to chemo- and radiotherapy, providing an innovative anti- tumor approach based on a ncRNA-related gene therapy. Therefore, ncRNAs could not only be useful as predictive and prognostic biomarkers but also serve as targets for the development of novel therapeutic strategies to overcome drug and radiation resistance in CRC. In this chapter, we discuss the involvement of ncRNAs in chemo- and radiotherapy resistance of CRC, highlighting the impact of these molecules in prediction of the treatment response and modifi cation of the therapy, and describing possible intracellular pathways involved in these processes.",
keywords = "Chemoresistance; Chemotherapy; miRNAs; Non-coding RNA; Predictive biomarkers; Radioresistance; Radiotherapy; Targeted therapy; Therapy response; Medicine (all); Biochemistry, Genetics and Molecular Biology (all)",
author = "Daniele Fanale and Marta Castiglia and Antonio Russo and Viviana Bazan",
year = "2016",
language = "English",
pages = "207--228",
booktitle = "Advances in Experimental Medicine and Biology - Non-coding RNAs in Colorectal Cancer",

}

TY - CHAP

T1 - Involvement of non-coding RNAs in chemo- and radioresistance of colorectal cancer

AU - Fanale, Daniele

AU - Castiglia, Marta

AU - Russo, Antonio

AU - Bazan, Viviana

PY - 2016

Y1 - 2016

N2 - Despite recent progress in understanding the cancer signaling pathways and in developing new therapeutic strategies, however, the resistance of colorectal cancer (CRC) cells to chemo- and radiotherapy represents the main hurdle to the successful treatment, leading to tumor recurrence and, consequently, a poor prognosis. Therefore, overcoming drug and radiation resistance, enhancing drug and radiation sensitivity of CRC cells, and improving the effi cacy of chemo- and radiotherapy have an important signifi cance in the treatment of CRC. The identifi cation of new molecular biomarkers which can predict therapy response and prognosis is one of the most signifi cant aims in pharmacogenomics and cancer research. Recent studies showed that non-coding RNAs (ncRNAs), such as microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), may play important roles in the regulation of chemo- and radioresistance of CRC, by controlling several signaling pathways, including cell cycle, proliferation, apoptosis and DNA damage repair. Recent data have demonstrated that selective modulation of the ncRNA activity can improve the response to chemo- and radiotherapy, providing an innovative anti- tumor approach based on a ncRNA-related gene therapy. Therefore, ncRNAs could not only be useful as predictive and prognostic biomarkers but also serve as targets for the development of novel therapeutic strategies to overcome drug and radiation resistance in CRC. In this chapter, we discuss the involvement of ncRNAs in chemo- and radiotherapy resistance of CRC, highlighting the impact of these molecules in prediction of the treatment response and modifi cation of the therapy, and describing possible intracellular pathways involved in these processes.

AB - Despite recent progress in understanding the cancer signaling pathways and in developing new therapeutic strategies, however, the resistance of colorectal cancer (CRC) cells to chemo- and radiotherapy represents the main hurdle to the successful treatment, leading to tumor recurrence and, consequently, a poor prognosis. Therefore, overcoming drug and radiation resistance, enhancing drug and radiation sensitivity of CRC cells, and improving the effi cacy of chemo- and radiotherapy have an important signifi cance in the treatment of CRC. The identifi cation of new molecular biomarkers which can predict therapy response and prognosis is one of the most signifi cant aims in pharmacogenomics and cancer research. Recent studies showed that non-coding RNAs (ncRNAs), such as microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), may play important roles in the regulation of chemo- and radioresistance of CRC, by controlling several signaling pathways, including cell cycle, proliferation, apoptosis and DNA damage repair. Recent data have demonstrated that selective modulation of the ncRNA activity can improve the response to chemo- and radiotherapy, providing an innovative anti- tumor approach based on a ncRNA-related gene therapy. Therefore, ncRNAs could not only be useful as predictive and prognostic biomarkers but also serve as targets for the development of novel therapeutic strategies to overcome drug and radiation resistance in CRC. In this chapter, we discuss the involvement of ncRNAs in chemo- and radiotherapy resistance of CRC, highlighting the impact of these molecules in prediction of the treatment response and modifi cation of the therapy, and describing possible intracellular pathways involved in these processes.

KW - Chemoresistance; Chemotherapy; miRNAs; Non-coding RNA; Predictive biomarkers; Radioresistance; Radiotherapy; Targeted therapy; Therapy response; Medicine (all); Biochemistry

KW - Genetics and Molecular Biology (all)

UR - http://hdl.handle.net/10447/225783

UR - http://www.springer.com/series/5584

M3 - Chapter

SP - 207

EP - 228

BT - Advances in Experimental Medicine and Biology - Non-coding RNAs in Colorectal Cancer

ER -